Uploaded on Mar 1, 2021
The adoption of transplant diagnostics (including both pre- and post-transplant screening) is expected to witness a significant rise with increasing prevalence of chronic diseases that can lead to organ failure.
Transplant Diagnostics Market Opportunity Analysis and Industry Forecast, 2027
Transplant Diagnostics Market - Global Opportunity Analysis & Industry
Forecast
2020- 2027
Transplant Diagnostics Market - Global Opportunity Analysis &
Industry Forecast
2020- 2027
Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay,
Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant
centers, Research laborat ories and academic institutes, Commercial Service Providers) - Global
Opportunity Analysis and Industry Forecast, 2020 - 2027
Transplant Diagnostics Market - Overview:
Increase in incidence of organ failure owing to growing cases of chronic diseases, rise in ageing population,
and increase in focus on R&D is expected to propel the growth of the global transplant diagnostics market.
Chronic diseases can lead to organ failure in patients, which could be a significant target audience for
transplant diagnostics procedures. However, difficulties in human leukocyte antigen (HLA) sequencing and
increasing worldwide organ shortage can hamper the market growth.
Transplant Diagnostics Market - Major Key Players
Major players operating in the market include Immucor, Inc. (TGI Capital), Bio-Rad Laboratories, Inc.,
Thermo Fisher Scientific Inc. F. Hoffmann-la Roche AG, Illumina Inc., Abbott Laboratories, Sigma-
Aldrich Corporation, Qiagen N. V., Olerup SSP AB (Allenex), and Diasorin S.P.A. Thermo Fisher occupies.
Read More@ https://www.alliedmarketresearch.com/transplant-diagnostics-market
Transplant Diagnostics Market & COVID-19
COVID-19 Scenario:
Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical
devices production including ventilators and diagnostics.
However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered.
Which may result in shortage of devices in certain locations.
Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to
notify the agency about changes that could affect availability of their products.
Get detailed COVID-19 impact analysis on the Market@ https://
www.alliedmarketresearch.com/request-for-customization/1135?reqfor=covid
Veterinary Medicine Market – Regional outlook
The market is evaluated based on its regional penetration, explaining the performance of the market in
each regional market covering regions such as North America (United States, Canada and Mexico), Europe
(Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South
America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South
Africa)
Get Free Sample PDF of Report@ https://
www.alliedmarketresearch.com/request-sample/1135
About Us:-
Allied Market Research (AMR) is a market research and business-consulting firm of Allied
Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business
solutions, consulting services, and insights on markets across 11 industry verticals. Adopting
extensive research methodologies, AMR is instrumental in helping its clients to make strategic
business decisions and achieve sustainable growth in their market domains. We are equipped
with skilled analysts and experts, and have a wide experience of working with many Fortune
500 companies and small & medium enterprises.
Visit Or Website@ https://www.alliedmarketresearch.com
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Comments